Why is FMC stock collapsing today?
FMC Corporation's stock fell 32% in pre-market trading after slashing its Q3 revenue forecast to $65M–$125M (down from $840M–$900M) and adjusting EBITDA to -$565M to -$510M. The company announced restructuring actions to improve competitiveness. Analysts have recently cut price targets, with Mizuho lowering it to $12. The broader market declined slightly, amplifying selling pressure.
How this was made
The 30-second read
Why it matters
The abrupt guidance revision eclipses prior analyst downgrades, making the news the primary catalyst for the stock's collapse.
Market read
FMC's sharp guidance cut and pre‑market plunge represent a high‑impact, time‑sensitive trading event.
What to watch
Potential upside from upcoming 2027‑2028 strategic initiatives not yet quantified.
Background
FMC had posted Q2 revenue of $867.1M, a 17% YoY decline, and a GAAP loss, setting a backdrop of deteriorating fundamentals.
Ticker impact
FMC issued a pre‑earnings update cutting Q3 revenue to $65‑$125M and Adjusted EBITDA to -$565M‑-$510M, triggering a 32% pre‑market plunge.
likely continued downside as investors price in the severe guidance cut and debt concerns
The new guidance represents a material downgrade from prior expectations and the stock already fell 32% pre‑open; no mitigating catalyst is mentioned.
Market effects
Agricultural chemicals sector faces heightened risk perception after FMC's guidance cut.
U.S. equities showed modest weakness, with the S&P 500 edging lower.
Limited to U.S. markets; no broader macro impact noted.
Counterpoint
If the debt reduction plan succeeds, FMC could be undervalued after the sell‑off.
Key entities
- ExecutivePierre Brondeau
CEO of FMC who announced the commercial restructuring actions.
